Literature DB >> 15763346

Heme oxygenase-1 levels and oxidative stress-related parameters in non-alcoholic fatty liver disease patients.

Lucia Malaguarnera1, Roberto Madeddu, Elisabetta Palio, Nicolò Arena, Mariano Malaguarnera.   

Abstract

BACKGROUND/AIMS: Non-alcoholic steatohepatitis (NASH) is a disorder that is histologically characterized by macrovesicular steatosis and lobular hepatitis with necrosis or ballooning degeneration and fibrosis. NASH can range from a benign condition to end-stage liver disease. The mechanisms promoting transition from steatosis to NASH appear to involve multiple cellular adaptations to the oxidative stress occurring when fatty acid metabolism is altered. We evaluated the relationship between lipid peroxidation and other oxidative stress biomarkers with changes in expression of heme oxygenase-1 (HO-1) in human hepatic steatosis ranging from simple steatosis to NASH.
METHODS: HO-1 expression, lipid peroxidation, ferritin and GSH levels were assayed from liver biopsies obtained from 60 subjects: 35 with NASH, 15 with simple steatosis and 10 controls.
RESULTS: The HO-1 expression was significantly increased in NASH patients and the increase reflected the severity of the disease. A significant correlation was observed between the increased levels of HO-1 and ferritin, and between the increased levels of HO-1 and lipid peroxidation. Moreover, NASH patients with lower levels of GSH exhibited higher expression of HO-1.
CONCLUSIONS: The induction of HO-1 is an adaptive response against oxidative damage elicited by lipid peroxidation and it may be critical in the progression of the disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15763346     DOI: 10.1016/j.jhep.2004.11.040

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  54 in total

Review 1.  Endocrine-disrupting chemicals and fatty liver disease.

Authors:  Charles E Foulds; Lindsey S Treviño; Brian York; Cheryl L Walker
Journal:  Nat Rev Endocrinol       Date:  2017-05-19       Impact factor: 43.330

2.  Nrf2 inhibits hepatic iron accumulation and counteracts oxidative stress-induced liver injury in nutritional steatohepatitis.

Authors:  Kosuke Okada; Eiji Warabi; Hirokazu Sugimoto; Masaki Horie; Katsutoshi Tokushige; Tetsuya Ueda; Nobuhiko Harada; Keiko Taguchi; Etsuko Hashimoto; Ken Itoh; Tetsuro Ishii; Hirotoshi Utsunomiya; Masayuki Yamamoto; Junichi Shoda
Journal:  J Gastroenterol       Date:  2012-02-28       Impact factor: 7.527

3.  The Protective Effect of Heme Oxygenase-1 against Intestinal Barrier Dysfunction in Cholestatic Liver Injury Is Associated with NF-κB Inhibition.

Authors:  Lijing Zhang; Zhenling Zhang; Bojia Liu; Yanling Jin; Yan Tian; Yi Xin; Zhijun Duan
Journal:  Mol Med       Date:  2017-08-09       Impact factor: 6.354

4.  Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial.

Authors:  Nasrin Sharifi; Reza Amani; Eskandar Hajiani; Bahman Cheraghian
Journal:  Endocrine       Date:  2014-06-27       Impact factor: 3.633

5.  Effects of amlodipine, captopril, and bezafibrate on oxidative milieu in rats with fatty liver.

Authors:  Zvi Ackerman; Mor Oron-Herman; Talma Rosenthal; Orit Pappo; Gabriela Link; Ben-Ami Sela; Maria Grozovski
Journal:  Dig Dis Sci       Date:  2007-08-22       Impact factor: 3.199

6.  In Children With Nonalcoholic Fatty Liver Disease, Cysteamine Bitartrate Delayed Release Improves Liver Enzymes but Does Not Reduce Disease Activity Scores.

Authors:  Jeffrey B Schwimmer; Joel E Lavine; Laura A Wilson; Brent A Neuschwander-Tetri; Stavra A Xanthakos; Rohit Kohli; Sarah E Barlow; Miriam B Vos; Saul J Karpen; Jean P Molleston; Peter F Whitington; Philip Rosenthal; Ajay K Jain; Karen F Murray; Elizabeth M Brunt; David E Kleiner; Mark L Van Natta; Jeanne M Clark; James Tonascia; Edward Doo
Journal:  Gastroenterology       Date:  2016-08-26       Impact factor: 22.682

7.  Up-regulation of heme oxygenase-1 in rat spleen after aniline exposure.

Authors:  Jianling Wang; Huaxian Ma; Paul J Boor; V M Sadagopa Ramanujam; G A S Ansari; M Firoze Khan
Journal:  Free Radic Biol Med       Date:  2009-12-04       Impact factor: 7.376

Review 8.  Natural heme oxygenase-1 inducers in hepatobiliary function.

Authors:  Giovanni Li Volti; David Sacerdoti; Claudia Di Giacomo; Maria-Luisa Barcellona; Antonio Scacco; Paolo Murabito; Antonio Biondi; Francesco Basile; Diego Gazzolo; Raul Abella; Alessandro Frigiola; Fabio Galvano
Journal:  World J Gastroenterol       Date:  2008-10-28       Impact factor: 5.742

Review 9.  Reactive oxygen and nitrogen species in steatotic hepatocytes: a molecular perspective on the pathophysiology of ischemia-reperfusion injury in the fatty liver.

Authors:  Megan J Reiniers; Rowan F van Golen; Thomas M van Gulik; Michal Heger
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

Review 10.  Molecular mechanisms involved in NAFLD progression.

Authors:  Mariano Malaguarnera; Michelino Di Rosa; Ferdinando Nicoletti; Lucia Malaguarnera
Journal:  J Mol Med (Berl)       Date:  2009-04-08       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.